Search

Search Constraints

You searched for: Author/Creator Ssebambulidde, Kenneth

Search Results

1. 869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial. (15th December 2022)

3. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial. Issue 8 (August 2019)

4. Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective Cohort. (17th June 2022)

5. Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis. (29th October 2020)

7. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials. (8th January 2020)

8. Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis. (28th November 2020)

9. Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial. Issue 12 (December 2022)